Disc Medicine, Inc.
DISC-3405
sickle cell disease (SCD)
Resolved
7days ago
Phase 1 readout · ~ Jun 30, 2026 estimated
What's at stake
Phase 1 trial results for DISC-3405 in sickle cell disease (SCD) are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 16h ago
“Initiated Phase 1b study in sickle cell disease in Q4 2025 with initial data expected in 2H 2026”